Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder With Anxious Distress”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT04080752
What this trial is testing

JNJ-61393215 in the Treatment of Depression

Who this might be right for
Major Depressive Disorder With Anxious Distress
Janssen Research & Development, LLC 222
Large-scale testing (Phase 3)Study completedNCT02196506
What this trial is testing

Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 837
Not applicableActive Not RecruitingNCT06698471
What this trial is testing

Relief From Stress Via Social Protection in Senegal

Who this might be right for
Distress, PsychologicalDepression - Major Depressive DisorderGeneralized Anxiety Disorder (GAD)
Georgetown University 748
Testing effectiveness (Phase 2)Study completedNCT02498392
What this trial is testing

An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress

Who this might be right for
Depressive DisorderAnxiety
Janssen Research & Development, LLC 161
Testing effectiveness (Phase 2)Looking for participantsNCT07065240
What this trial is testing

Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Who this might be right for
Major Depressive Disorder (MDD)Major Depressive Disorder With Anxious Distress
Seaport Therapeutics 360
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07161700
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)

Who this might be right for
Major Depressive Disorder (MDD)Major Depressive Disorder With Anxious Distress
Seaport Therapeutics 360
Not applicableLooking for participantsNCT07212075
What this trial is testing

Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups

Who this might be right for
Diabetes (DM)Diabete MellitusDiabete Type 1+17 more
Forschungsinstitut der Diabetes Akademie Mergentheim 1,809